Research and development
Own R&D center is one of Akrikhin's key advantages. This is an independent chemical and technological center specialising in the development of new medicines in full compliance with international GMP standards
10+
launches per year
50+
medications under
active development
active development
100+
medications were developed
in 2000–2023
in 2000–2023
The Company's product portfolio development strategy is based on developing the first generics, new forms of existing medicines and new combinations
Different dosage forms
Akrikhin is focused on developing new medicines of the most socially significant therapeutic groups
Tablets
Capsules
Creams
Gels
Emulsions
Modern process equipment
Our R&D center is fitted with the most modern process equipment and high-precision analytical instruments